Literature DB >> 8948357

Optimization of permanent 125I prostate implants using fast simulated annealing.

J Pouliot1, D Tremblay, J Roy, S Filice.   

Abstract

PURPOSE: Treatment planning of ultrasound-guided transperineal 125I permanent prostatic implants is a time-consuming task, due to the large number of seeds used and the very large number of possible source arrangements within the target volume. The goal of this work is to develop an algorithm based on fast simulated annealing allowing consistent and automatic dose distribution optimization in permanent 125I prostatic implants. METHODS AND MATERIALS: Fast simulated annealing is used to optimize the dose distribution by finding the best seed distribution through the minimization of a cost function. The cost function includes constraints on the dose at the periphery of the planned target volume and on the dose uniformity within this volume. Adjustment between peripheral dose and the dose uniformity can be achieved by varying the weight factor in the cost function.
RESULTS: Fast simulated annealing algorithm finds very good seed distributions within 20,000 iterations. The computer time needed for the optimization of a typical permanent implant involving 60 seeds and 14 needles is approximately 15 min. An additional 5 min are necessary for isodose distribution computations and miscellaneous outputs.
CONCLUSION: The use of fast simulated annealing allows for an efficient and rapid optimization of dose distribution. This algorithm is now routinely used at our institution in the clinical planning of 125I permanent transperineal prostate implants for early stage prostatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948357     DOI: 10.1016/s0360-3016(96)00365-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Optimization of light sources for prostate photodynamic therapy.

Authors:  Martin D Altschuler; Timothy C Zhu; Jun Li; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2005-04-22

2.  Fast patient-specific Monte Carlo brachytherapy dose calculations via the correlated sampling variance reduction technique.

Authors:  Andrew Sampson; Yi Le; Jeffrey F Williamson
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

3.  Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.

Authors:  Martin D Altschuler; Timothy C Zhu; Jun Li; Stephen M Hahn
Journal:  Med Phys       Date:  2005-12       Impact factor: 4.071

4.  CT-guided 125I brachytherapy for recurrent ovarian cancer.

Authors:  Ping Liu; Lina Tong; Bin Huo; Dong Dai; Wenxin Liu; Ke Wang; Ying Wang; Zhi Guo; Hong Ni
Journal:  Oncotarget       Date:  2017-03-04

5.  A novel greedy heuristic-based approach to intraoperative planning for permanent prostate brachytherapy.

Authors:  Bin Liang; Fugen Zhou; Bo Liu; Junjie Wang; Yong Xu
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

6.  Post-implant analysis in permanent breast seed implant: automated plan reconstruction using simulated annealing.

Authors:  Elizabeth Watt; Matthew Skarsgard; Michael Roumeliotis; Siraj Husain; Tyler Meyer
Journal:  J Contemp Brachytherapy       Date:  2019-02-28

7.  Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer.

Authors:  Georgina Fröhlich; Gyula Geszti; Júlia Vízkeleti; Péter Ágoston; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2019-09-03       Impact factor: 3.621

8.  A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate brachytherapy.

Authors:  Nicolas Boussion; Ulrike Schick; Gurvan Dissaux; Luc Ollivier; Gaëlle Goasduff; Olivier Pradier; Antoine Valeri; Dimitris Visvikis
Journal:  J Contemp Brachytherapy       Date:  2021-10-07

9.  Optimized planning for intraoperative planar permanent-seed implant.

Authors:  Albert Y C Fung; Howard I Amols; Marco Zaider
Journal:  J Appl Clin Med Phys       Date:  2002       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.